Societal CDMO competitors and similar companiesClear all
Societal CDMO's competitors and similar companies include Amicus Therapeutics, Zogenix and Array BioPharma.
 Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | |
Founding Date | Founding Date 2006 | Founding Date 2002 | Founding Date 2006 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Gainesville, US HQ Gainesville, US San Diego, US | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Emeryville, US HQ Maidenhead, GB | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US |
Employees | Employees 21316% decrease | Employees 58415% increase | Employees 14157% increase | Employees 29843% increase |
Valuation ($) | Valuation ($) 97.4 m | Valuation ($) 3.2 b | Valuation ($) 1.5 b | Valuation ($) N/A |
Twitter followers | Twitter followers N/A | Twitter followers 2.1 k | Twitter followers 2 | Twitter followers N/A |
Employee Rating | Employee Rating 3.4 | Employee Rating 2.9 | Employee Rating 2.7 | Employee Rating 3.5 |
Financial | ||||
Revenue (est.) | Revenue (est.) $90.2m (FY, 2022) | Revenue (est.) $329.2m (FY, 2022) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $173.8m (FY, 2018) |
Cost of goods | Cost of goods $67.1m (FY, 2022) | Cost of goods $38.6m (FY, 2022) | Cost of goods $4.8m (FY, 2021) | Cost of goods $59.4m (FY, 2018) |
Gross profit | Gross profit $23.1m (FY, 2022) | Gross profit $290.6m (FY, 2022) | Gross profit N/A | Gross profit $114.4m (FY, 2018) |
Net income | Net income ($19.9m) (FY, 2022) | Net income ($236.6m) (FY, 2022) | Net income ($227.4m) (FY, 2021) | Net income ($147.7m) (FY, 2018) |
For sources of this data, please see the company profile
View company profiles
Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View companyZogenix
HQ
Emeryville, US
Employees
141
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyArray BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company